Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Bluesky
Twitter
Facebook
Telegram
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • TabsTabs
  • DataData
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
  • Methods
    • Study design and analytic overview
    • Target population
    • Interventions and comparators
    • Perspective
    • Time horizon and cycle length
    • Model structure
    • Clinical inputs
    • Utilities and QALYs
    • Life-years
    • Costs
    • VEN+AZA drug acquisition costs
    • Azacitidine costs
    • Hospitalization and care costs
    • Sensitivity analyses
    • Model validation
    • Outcomes
    • Discounting
  • Results
    • Health-state occupancy
    • Resource use breakdown
    • QoL mapping
    • Base-case analysis
    • Probabilistic sensitivity analysis
    • One-way sensitivity analyses
  • Discussion
  • Limitations
  • Conclusion
  • References
  • Additional information
    • Conflict of interest
    • Ethical statements
    • Artificial Intelligence (AI) use
    • Funding
    • Author contributions
    • Author ORCIDs
    • Data availability
  • Supplementary materials
Subscribe to email alerts for current Article's categories
Powered by